MW MARKET WATCH
INFQ
Infleqtion, Inc. — NYSE • Technology • Quantum Computing — Neutral Atom Platform
$8.90 -7.48% (03/20)
$1.93B
Market Cap
216.5M
Shares Out.
142.3M
Float
2.47%
Short Float
33.7
RSI(14)
$9.01 – $27.50
52W Range
Feb 17, 2026
IPO Date
$1.14
ATR(14)
NYSE Quantum Computing Neutral Atom
20 March 2026 • Real-time data via MarketWatch Gateway
INFQ Chart
Click to enlarge — Daily chart with technicals
B
Global Conviction
Speculative Long — High Risk / High Reward
Bias: Bullish Long-Term · Confidence: 62% · Profile: Speculative / Deep Tech
🔬 What they do: Infleqtion builds neutral-atom quantum computers, precision sensors, and quantum software. Unlike IBM/Google who use superconducting qubits, they leverage neutral atoms — naturally identical, highly scalable, and backed by Nobel Prize-winning physics. Revenue $31M TTM, growing +163% YoY, with real government and enterprise customers today.
⚡ Current Setup: Post-IPO dump — down 67% from the Feb 17 high of $27.50, now trading near the 52W low ($9.01). RSI at 33.7 suggests oversold territory. Massive institutional selling pressure from SPAC unwinding, but fundamentals intact. The sell-off looks indiscriminate.

✅ 3 Reasons to Buy

  • 🌍 First-mover — only neutral-atom quantum company publicly traded
  • 💰 Real traction — 100-qubit system live at UK National Quantum Centre (Mar 15)
  • 🤝 Strategic partnerships — NVIDIA NVQLink, DOE National Labs, NASA supply chain

❌ 3 Reasons to Avoid

  • 🔥 Burning cash — -$21M FCF/year, runway ~3 years then needs more capital
  • 📉 Post-SPAC pressure — heavy redemptions + warrants likely outstanding
  • ⏳ Pre-commercial — quantum computing at scale still 3-5+ years out

🔬 Business Model

Infleqtion was founded in 2007 (originally as ColdQuanta) and is headquartered in Louisville, CO. They are the world's leading neutral-atom quantum technology company with 130+ PhD physicists/engineers and 230+ patents. Unlike competitors using superconducting or photonic approaches, Infleqtion leverages neutral atoms — described as "nature's perfect qubit" — for scalability to millions of qubits at room-compatible operating conditions. Infleqtion.com

💻
Quantum Computing
~50% of revenue
Neutral-atom QPUs for enterprise + government. Roadmap: 100 logical qubits by 2028. UK 100-qubit system deployed Mar 2026.
🛰️
Quantum Sensing
~35% of revenue
Atomic clocks, quantum RF receivers, inertial navigation for GPS-denied environments. Defense + space applications.
💡
Integrated Photonics
~15% of revenue
PICs (photonic integrated circuits) reducing quantum system size/cost by 90%. Key enabler for commercial deployment at scale.

⚛️ Why Neutral Atoms? The Tech Differentiation

  • Naturally identical qubits — every neutral atom of the same element is exactly identical, unlike manufactured superconducting circuits with fabrication variations
  • Scalability to millions — atomic arrays can theoretically scale to millions of qubits vs ~1,000 for superconducting approaches today
  • Room-temperature compatible — no dilution refrigerators needed at the atom level (trap infrastructure still needed, but much simpler)
  • Error correction — dual-species atom arrays with low-crosstalk measurements for fault-tolerant quantum computing
  • Nobel Prize physics — built on the same atomic physics that won the 2012 Nobel Prize (Haroche & Wineland)

📍 Global Footprint

Operational installations in US, UK, Japan, and Australia. The UK deployment (March 2026) at the National Quantum Computing Centre is particularly significant — it represents the first commercial-scale neutral-atom system outside the US. The appointment of a Managing Director for Australia (March 12) signals aggressive international expansion. Business Wire · Mar 15

🗺️ Quantum Computing Roadmap

2024–2025
~50 Qubits
Early systems, proof of concept deployments
Mar 2026
100 Qubits
UK NQCC deployment — operational today ✅
2026–2027
Logical Qubits
Error-corrected logical qubit demos, fault tolerance
2028
100+ Logical
Practical quantum advantage for specific workloads
2030+
Millions
Universal fault-tolerant quantum computing at scale

📰 Recent News & Catalysts

Mar 15, 2026Bullish
Infleqtion Delivers UK's Only Operational 100-Qubit System at NQCC
Major milestone — first 100-qubit neutral-atom system deployed outside the US. Validates hardware roadmap. Stock reacted negatively due to broader market selloff but fundamentally very positive. Business Wire
Mar 11, 2026Bullish
$3.9M Federal Funding — DOE for Quantum Chemistry & Materials Science
Non-dilutive federal grant. Validates government confidence in Infleqtion's technology. Adds to the growing contract base. Business Wire
Mar 10, 2026Bullish
NVIDIA NVQLink Partnership — Quantum Accelerated Supercomputing at GTC 2026
Integration with NVIDIA's GPU supercomputing stack. Positions INFQ as a hybrid quantum-classical computing player. NVQLink is NVIDIA's quantum-classical interconnect. Massive strategic validation. Business Wire
Mar 9, 2026Bullish
Expands Partnerships with U.S. DOE National Laboratories
Multiple DOE national labs (Oak Ridge, Argonne, etc.) expanding quantum research collaborations. Government is the primary early quantum customer — this is exactly the right revenue base for this stage. Business Wire
Feb 25, 2026Bullish
Monarch Quantum (Infleqtion subsidiary) Selected for NASA Space-Based Quantum Gravity Gradiometer
Quantum sensing contract for NASA space mission. Shows the breadth of Infleqtion's quantum sensing capabilities beyond Earth-based defense. PR Newswire
Feb 17, 2026Neutral
IPO via SPAC Merger with Churchill Capital XI — First Neutral-Atom Company Public
Opened at +14.13% on first day. Has since sold off -67% as SPAC arbitrageurs and redemptions played out. Classic post-SPAC dynamics — not a fundamental story. Business Wire · IPO day
🌐 Macro Tailwind: UK government committed $2.5B to quantum computing (Mar 17 announcement). Infleqtion is the only company with a live 100-qubit system in the UK right now. This is a direct beneficiary of that spending. Barron's · Mar 17

📊 Fundamentals

Metric TTM (Sep '25) FY 2024 FY 2023 Signal
Revenue $30.9M $28.8M $10.9M +163% YoY ✅
Gross Profit $14.5M $10.4M $4.4M 46.9% margin
R&D Spend $20.0M $22.3M $3.8M Heavy investment
Operating Loss -$29.2M -$38.6M -$55.8M Improving ↑
Net Loss -$28.7M -$53.2M -$52.8M Narrowing ↑
Free Cash Flow -$20.9M -$35.3M -$51.0M Improving fast ✅
Cash + ST Invest. $76.3M $47.9M $40.1M ~3.5yr runway ✅
Total Debt $5.5M $6.1M $3.7M Near zero ✅
Gross Margin 46.9% 36.0% 40.5% Expanding ✅
EPS (Diluted) -$0.65 -$1.34 -$1.50 Improving ✅
P/B Ratio 1.21x — — Below peers
StockAnalysis· Mar 2026 Finviz· live

💡 Key Takeaway on Fundamentals

The most important trend: FCF burn improved from -$51M (FY2023) to -$35M (FY2024) to -$21M (TTM) — that's a 60% reduction in cash consumption in 2 years while revenue tripled. This is the trajectory of a company approaching breakeven. With $76M cash and ~$21M annual burn, they have 3.5+ years of runway without needing to raise capital. The IPO proceeds (SPAC merger) added meaningful cash to the balance sheet.

🏗️ Capital Structure & Dilution Risk

⚠️ SPAC Merger Background: Infleqtion went public via merger with Churchill Capital Corp XI (CCXI) on Feb 17, 2026. SPAC mergers typically come with: (1) warrants outstanding, (2) SPAC redemptions creating supply overhang, (3) lock-up periods for insiders. The -67% post-IPO move is largely explained by these SPAC mechanics, not fundamental deterioration. SEC EDGAR

Share Structure

Moderate
  • Shares Outstanding: 216.47M (post-SPAC)
  • Float: 142.34M (65.7% of total)
  • Insider Ownership: 34.24% — very high alignment
  • Institutional Ownership: 26.60%
Insider lock-up expiry will be a key date to monitor

SPAC Warrants

Elevated
  • Churchill Capital XI warrants likely outstanding at exercise prices ~$11.50
  • Typical SPAC: 1 warrant per unit, exercisable 1 year post-IPO
  • With stock at $8.90, warrants are currently out-of-the-money
  • Warrant overhang typically resolves once stock stabilizes
Watch for Form 4 filings and 8-K warrant amendments SEC Form 4

Toxic Finance Check

Low
  • No WC Wainwright / Maxim Group / Dawson James involvement detected
  • IPO via Churchill Capital (reputable SPAC sponsor)
  • No ATM program detected post-IPO (too early — Feb 2026)
  • Debt/Equity: 0.00 — no toxic convertibles
Clean financing — no toxic fund fingerprints detected

Cash Runway

Low–Moderate
  • Cash + ST Investments: $76.3M
  • FCF burn rate: ~$21M/year (improving)
  • Runway: ~3.5 years at current pace
  • Revenue growing at 163% YoY — burn could slow further
Comfortable runway — next raise not urgent before 2028

🔀 Short Interest & Market Structure

MetricValueContext
Short Interest3.52M sharesLow absolute level
Short Float2.47%Very low — no squeeze potential but no short pressure either
Short Ratio (Days to Cover)1.28 daysShorts could cover very quickly
Avg Daily Volume2.75M sharesReasonable liquidity for a small cap
Relative Volume1.45xAbove average — elevated interest today
Options AvailableYesCalls and puts tradable
Finviz Short Data· live

📌 Market Structure Interpretation

With only 2.47% short float, the sell-off from $27.50 to $8.90 is NOT driven by short sellers — it's pure liquidation selling from SPAC arbitrageurs and momentum traders who were disappointed by the early post-IPO price action. That's actually good news: once the weak hands have finished selling, there's no short covering mechanism, meaning recoveries could be gradual but sustainable.

📈 Technical Analysis

IndicatorValueSignal
RSI (14)33.7⚠️ Approaching oversold (below 35)
SMA 20-20.96% below🔴 Bearish
SMA 50-34.87% below🔴 Bearish
SMA 200-35.62% below🔴 Bearish (new stock — limited history)
ATR (14)$1.14⚡ High volatility — 12.8% daily range
52W High$27.50📍 Price is 67% below the high
52W Low$9.01🟡 Trading just above 52W low
Prev Close$9.62📉 Today: -7.48%
🔬 Wyckoff Phase: Post-IPO stocks often go through a classic Selling Climax → Automatic Rally → Secondary Test pattern. INFQ is potentially in a Selling Climax / Secondary Test phase near the 52W low ($9.01). RSI at 33.7 supports this interpretation. Watch for a volume spike + reversal as the Sign of Strength.

Key Levels

LevelPriceSignificance
🔴 Major Resistance$13.00–$14.00Previous consolidation zone + SMA20 area
🟡 Minor Resistance$10.50–$11.00Recent reaction highs
🟢 Current Price~$8.90Near 52W low — critical zone
🔵 Key Support$9.00–$9.0152W Low — Must hold for bullish thesis
⚠️ Stop Zone$7.50–$8.00Below 52W low — invalidation territory

🏆 Competitive Landscape

Company Ticker Approach Market Cap Revenue TTM Rev Growth Logical Qubits Target
Infleqtion INFQ Neutral Atom $1.93B $31M +163% 100+ by 2028
IonQ IONQ Trapped Ion ~$4.5B ~$43M +95% 35 AQ (algorithmic)
Rigetti Computing RGTI Superconducting ~$1.5B ~$12M +40% 84 qubits (physical)
D-Wave Quantum QBTS Annealing ~$1.2B ~$9M +30% N/A (annealing)
IBM Quantum IBM Superconducting Diversified Div. — 133 (Eagle) today
Yahoo Finance peers· live

⚛️ Why Neutral Atoms vs Trapped Ions vs Superconducting

Superconducting (IBM, Google, Rigetti): Fastest gates but require dilution refrigerators near absolute zero, hard to scale beyond ~1,000 qubits, and each qubit is slightly different (manufacturing variation).

Trapped Ion (IonQ): High fidelity, but slow gate speeds and complexity of ion trap infrastructure limits scaling.

Neutral Atom (Infleqtion, QuEra): Best theoretical scaling path — atoms are identical, can be arranged in 2D/3D arrays, and integrated photonics can shrink hardware dramatically. Most likely path to the millions of qubits needed for commercial quantum advantage.

⚠️ Risk Analysis

6/10
Risk Score

Risk Profile: Elevated (Deep Tech Pre-Commercial)

INFQ is a speculative deep tech play with genuine technology but uncertain commercialization timeline. The primary risks are execution, dilution from SPAC warrants, and the inherent uncertainty of quantum computing timelines. The balance sheet is solid, toxic finance is absent.

SPAC Warrants Cash Burn Execution Risk Competition Balance Sheet

SPAC Warrant Overhang

Elevated
  • Churchill Capital XI warrants typically exercisable at $11.50
  • At $8.90, warrants are OTM — no immediate pressure
  • However if stock recovers to $11.50+, warrant holders may exercise → dilution
  • Total potential dilution from warrants: typically 10-15% of post-merger shares
Probability
Impact
Monitor Form 4 filings and warrant amendment 8-Ks

Quantum Timeline Risk

Elevated
  • Quantum advantage for commercial workloads remains 3-5+ years away
  • Multiple "winter" scenarios in quantum history — timelines always slip
  • 100-qubit system impressive but logical qubits (error-corrected) are what matters commercially
  • Competitors (IBM, Google) spending 100x more on R&D
Probability
Impact
Quantum sensing business provides revenue bridge — key differentiator vs pure-play QC companies

Cash Burn & Future Raises

Moderate
  • FCF burn: ~$21M/year (improving rapidly)
  • $76M cash → ~3.5 years runway
  • Will likely need to raise capital in 2028-2029 window
  • Risk: dilutive raise at depressed prices if QC timeline slips
Probability
Impact
Revenue trajectory (163% growth) may allow near-breakeven by 2027-2028

Competition & Consolidation

Moderate
  • Google, IBM, Microsoft spending $1B+ each on quantum annually
  • Microsoft pivoting to topological qubits (potential leap-frog)
  • IonQ (trapped ion) well-funded and ahead on revenue
  • QuEra (also neutral atom) — private but well-funded competitor
Probability
Impact
Neutral atom remains the most scalable approach — Infleqtion has a genuine moat here

Geopolitical / Defense Risk

Low–Moderate
  • Heavy exposure to US government / defense contracts (positive near-term)
  • Risk: budget cuts or defense realignment under new administration
  • UK $2.5B quantum commitment is a major tailwind
  • Export controls on quantum technology could limit international expansion
Probability
Impact
Quantum security is bipartisan — unlikely to face budget cuts

Post-SPAC Liquidation Pressure

Low (Ongoing)
  • SPAC arb funds typically sell within 30-90 days post-merger
  • IPO was Feb 17 — currently 31 days post-IPO
  • Selling pressure likely ~60-70% exhausted based on price action
  • Lock-up expiry (typically 6 months post-IPO) = ~August 2026 watch date
Remaining Pressure
Impact
The worst of SPAC selling is likely behind us at -67% from high

🧠 Why Is INFQ Down 67% From Its High?

The collapse from $27.50 to $8.90 is almost entirely a SPAC mechanics story, not a fundamental story. SPAC IPOs routinely see 50-80% drawdowns as: (1) SPAC arb funds that bought cheap units pre-merger dump shares, (2) retail excitement fades, (3) no earnings = no natural institutional buyer base yet. The actual business — deploying quantum systems in UK, partnering with NVIDIA, winning federal contracts — has had a GREAT month of March 2026. The stock tells a different story because the market structure is broken post-SPAC.

📡 Social Radar

🔍 Pump & Dump Score: 0/6

No sudden 5x mention spike
No new accounts spamming
No specific price promises
IPO price decline (not pump)
Institutional coverage present
Float large enough (142M)
✅ Clean — No Pump & Dump Indicators

🌍 Macro Context

Asset / EventStatusINFQ Impact
UK Quantum Budget ($2.5B)Active ✅Direct beneficiary — only 100-qubit system in UK
US CHIPS & Quantum ActOngoing ✅Federal grants pipeline (just got $3.9M more)
NVIDIA GTC 2026Just happened ✅NVQLink partnership validated — quantum/GPU hybrid thesis
Q-Day ConcernsGrowingGovernment urgency around quantum encryption breaking → more defense contracts
AI Spending WaveOngoingHybrid quantum-classical workloads (NVIDIA partnership) benefit from AI capex cycle
Tariff / Trade WarRiskLimited direct impact — primarily government contracts, not consumer hardware
Risk-Off Market (2026 YTD)HeadwindSmall-cap speculative tech hit hardest in risk-off — explains post-IPO compression
🔑 Key Macro Thesis: Quantum computing is being treated as a national security priority by the US, UK, EU, Japan and Australia — all countries where Infleqtion has operations. Government spending on quantum is growing faster than any other tech sector and is largely immune to normal budget cycles. INFQ is arguably the best-positioned pure-play to capture this secular wave.

📍 Entry Zone & Bottom Estimation

📊 Price Zone Analysis

Optimistic — Has Bottomed $9.00 52W Low + RSI oversold + SPAC selling exhausted
Base Case Entry Zone $8.00–$9.50 Accumulation zone near 52W low; scale in gradually
Bear Case — More Selling $6.00–$7.00 Lock-up expiry wave (Aug 2026) + continued risk-off
Confidence: 58% — 3 confluences (52W low, RSI 33.7, SPAC selling arc complete)
⚠️ Key Risk Date: Lock-up expiry ~August 17, 2026 (6 months post-IPO). Insiders hold 34.24% of shares. If they sell, that's a potential 74M share overhang. Size positions accordingly and watch for 8-K lock-up amendment filings.

🎯 Trade Idea

INFQ Speculative Long Medium Term (3-9 months)
Entry Zone
$8.50 – $9.50
Scale in; current price $8.90. Near 52W low. RSI 33.7.
Stop Loss
$7.20
-18% from entry midpoint. Below any reasonable support structure.
Target 1
$13.00
+44% — Previous resistance / SMA20 recovery zone.
Target 2
$18.00
+100% — Mid-range recovery. R/R = 1:5.5 from entry.

💡 Trade Thesis

INFQ is a rare combination: the only publicly traded neutral-atom quantum company, with real operational deployments (UK 100-qubit system), strategic validation (NVIDIA, DOE), and a balance sheet that provides ~3.5 years of runway. The stock is 67% off its IPO high due entirely to SPAC mechanics, not business deterioration. At $8.90 near the 52W low with RSI at 33.7, the risk/reward for a patient speculative position is compelling.

🚀 Key Catalysts to Watch

  • Q1 2026 earnings (first as public company) — revenue growth confirmation
  • Additional government contracts (US Quantum Initiative, EU Quantum Flagship)
  • Analyst initiations from tier-1 banks post-IPO quiet period (~May 2026)
  • Additional NVIDIA/tech partner announcements
  • Logical qubit demonstration (major inflection point for sentiment)
❌ Invalidation: Close below $7.20 (stop loss), or: (1) missed quantum milestones with negative guidance, (2) surprise dilutive equity raise below current price, (3) loss of key government contracts. Also watch lock-up expiry (Aug 2026) — reduce size beforehand if stock has recovered significantly.
⚖️ Position Sizing: This is a high-risk speculative position. Max 2-3% of portfolio. Consider buying in 3 tranches: 1/3 now (~$8.90), 1/3 if it tests $8.00, 1/3 on first sign of reversal. Do not chase above $11.00 — wait for a new base to form first.

📋 Final Grade & Summary

B
Conviction Grade
Speculative Long — Controlled Risk Entry Near 52W Low
Bias: Bullish Long-Term · Confidence: 62% · Profile: Deep Tech / Speculative

🔑 Key Positives

  • ✅ Only publicly traded neutral-atom quantum company
  • ✅ Revenue growing +163% YoY with real government contracts
  • ✅ 100-qubit system deployed and operational in UK (Mar 2026)
  • ✅ NVIDIA NVQLink — strategic validation from most important AI hardware company
  • ✅ $76M cash, near-zero debt, 3.5yr runway
  • ✅ FCF burn improving at pace: -$51M → -$35M → -$21M

⚠️ Key Risks

  • 🔴 SPAC warrants outstanding — potential dilution at $11.50+
  • 🔴 Lock-up expiry August 2026 — 34% insider overhang
  • 🟡 Quantum timeline uncertainty — commercial advantage 3-5+ years away
  • 🟡 Pre-profitability — will need capital raise eventually (2028+)
  • 🟡 Competitive: Google/IBM/Microsoft spending 100x more on QC

🧠 Mindset Tip for INFQ Traders

Don't confuse "great technology" with "great trade." Infleqtion might genuinely be building the quantum computers of the future — but the stock could still go to $5 before it goes to $30 if the lock-up expires badly or if a broader market risk-off hits. Size this position for the scenario where you're wrong, not the scenario where you're right. Small position, patient timeline, and let the business results drive the stock — not the hype cycle.

📚 Sources

Infleqtion.com· live Yahoo Finance INFQ· live Finviz· live StockAnalysis Financials· Mar 2026 StockAnalysis Balance Sheet· Mar 2026 Business Wire UK 100Q· Mar 15, 2026 Barron's UK Quantum Budget· Mar 17, 2026 SEC EDGAR INFQ
Verdict Business News Fonda. Risques Social Trade